Assignee
IN3BIO LTD
BM·9 granted patents·3 pending applications·9 citations·filing 2016–2024
Top patents by PatentIndex Score
12 records- 0190US11198716B2Recombinant proteins and their therapeutic usesIN3BIO LTD·Filed 2017·Granted Dec 14, 2021·6 cites·15 claims
- 0287US12570708B2Recombinant proteins and their therapeutic usesIN3BIO LTD·Filed 2024·Granted Mar 10, 2026·0 cites·9 claims
- 0387US12030920B2Recombinant proteins and their therapeutic usesIN3BIO LTD·Filed 2021·Granted Jul 9, 2024·1 cites·12 claims
- 0479US11419923B2Self-assembling synthetic proteinsIN3BIO LTD·Filed 2020·Granted Aug 23, 2022·1 cites·9 claims
- 0576US12134662B2Synthetic proteins and therapeutic uses thereofIN3BIO LTD·Filed 2018·Granted Nov 5, 2024·1 cites·19 claims
- 0673US12433939B2Self-assembling synthetic proteins comprising cholera toxin beta subunitIN3BIO LTD·Filed 2022·Granted Oct 7, 2025·0 cites·9 claims
- 0759US12258389B2Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitorsIN3BIO LTD·Filed 2021·Granted Mar 25, 2025·0 cites·7 claims
- 0848US2022305105A1Stabilized chimeric synthetic proteins and therapeutic uses thereofIN3BIO LTD·Filed 2020·Application pending·0 cites
- 0945US12257245B2Methods and compositions for inhibition of EGF/EGFR pathway in combination with anaplastic lymphoma kinase inhibitorsIN3BIO LTD·Filed 2019·Granted Mar 25, 2025·0 cites·3 claims
- 1044US2022378891A1Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitorsIN3BIO LTD·Filed 2020·Application pending·0 cites
- 1142US12595297B2Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitorsIN3BIO LTD·Filed 2016·Granted Apr 7, 2026·0 cites·5 claims
- 1242US2019358320A1Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitorsIN3BIO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IN3BIO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →